Adverse kidney events with initiation of <scp>SGLT2</scp> inhibitors versus <scp>DPP4</scp> inhibitors in diabetic people with a history of acute kidney injury
SGLT2i therapy demonstrated consistent benefits across different AKI intervals and recovery levels, making it a preferable option for patients at risk of AKI.
Authors
- Tze‐Fan Chao (ORCID: https://orcid.org/0000-0002-6587-3094)
- Yi‐Wei Kao (ORCID: https://orcid.org/0000-0002-7891-9514)
- Yi‐Hsin Chan (ORCID: https://orcid.org/0000-0002-1406-8503)
- Shao‐Wei Chen (ORCID: https://orcid.org/0000-0003-1674-1295)
- Yu‐Wen Cheng (ORCID: https://orcid.org/0000-0001-8936-027X)
Institutions
- Fu Jen Catholic University (TW)
- National Yang Ming Chiao Tung University (TW)
- Chang Gung University (TW)
- Ming Chuan University (TW)
- Taipei Veterans General Hospital (TW)
- Chang Gung Memorial Hospital (TW)
- Linkou Chang Gung Memorial Hospital (TW)
Publication Details
- Journal
- European Journal of Clinical Investigation
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1111/eci.70080
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chang Gung Memorial Hospital